Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS)

Medical Hypotheses

Volumn 74, Issue 3, 2010, Pages 513-520

  Blum, Kenneth ^a,c,d,g   Chen, Thomas J H ^b   Chen, Amanda L H ^c   Madigan, Margaret ^d   Downs, B William ^d   Waite, Roger L ^d   Braverman, Eric R ^c,e   Kerner, Mallory ^c   Bowirrat, Abdalla ^f   Giordano, John ^g   Henshaw, Harry ^g   Gold, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c Department of Engineering and Management of Advanced Technology ^*  (United States)

^d LifeGen Inc   (United States)

^e Hospital for Special Surgery   (United States)

^f ZIV MEDICAL CENTER   (Israel)

^g Department of Holistic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE; DOPAMINE 2 RECEPTOR; ENDORPHIN;

ADDICTION; ALCOHOLISM; ALLELE; ARTICLE; BLUNTED AFFECT; DOPAMINE RELEASE; EMOTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HYPOTHALAMUS; MESOLIMBIC DOPAMINERGIC SYSTEM; MUSIC THERAPY; NEUROLOGIC DISEASE; NUCLEUS ACCUMBENS; ORBITAL CORTEX; REWARD; REWARD DEFICIENCY SYNDROME; SUBSTANCE ABUSE; THERAPY EFFECT; VENTRAL TEGMENTUM;

AUDITORY PERCEPTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIMBIC SYSTEM; MENTAL DISORDERS; MODELS, GENETIC; MODELS, NEUROLOGICAL; MUSIC; MUSIC THERAPY; POLYMORPHISM, SINGLE NUCLEOTIDE; REWARD;

EID: 77649271876     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.008     Document Type: Article

References (64)

1. Cross I. Comments on music, etiology, and evolution. Ann NY Acad Sci 2005, 1060:3-5.
2. Huron D. Is music an evolutionary adaptation?. Ann NY Acad Sci 2001, 930:43-61.
3. Slobada J.A., Juslin P. Psychological perspectives on music and emotion. Music and emotion: theory and research 2001, 71-104. Oxford University Press, Oxford. P. Juslin, J.A. Sloboda (Eds.).
4. Trehub S.E. The developmental origins of musically. Nat Neurosci 2003, 6:669-673.
5. Blood A.J., Zatorre R.J. Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion. Proc Natl Acad Sci USA 2001, 25(98):11818-11823.
6. Blood A.J., Zatorre R.J., Bermudez P., Evans A.C. Emotional responses to pleasant and unpleasant music correlate with activity in paralimbic brain regions. Nat Neurosci 1999, 2:382-2387.
7. Panksepp J. At the interface of the affective, behavioral, and cognitive neurosciences: decoding the emotional feelings of the brain. Brain Cognit 2003, 52:4-14.
8. Mays K.L., Clark D.L., Gordon A.J. Treating addiction with tunes: a systematic review of music therapy for the treatment of patients with addictions. Subst Abus 2008, 29:51-59.
9. Menon V., Levitin D.J. The rewards of music listening: response and physiological connectivity of the mesolimbic system. Neuroimage 2005, 28:175-184.
10. 2 receptor gene in alcoholism. J Am Med Assoc 1990, 63:2055-2060.
11. Volkow N.D., Wang G.J., Newcorn J., et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement I adults with attention deficit disorder. Arch Gen Psychiatr 2007, 64:932-940.
12. Sato S., Chiba T., Nishiyama S., Kakiuchi T., Tsukada H., Hatano T., et al. Decline of striatal dopamine release in Parkin-deficient mice shown by ex vivo autoradiography. J Neurosci Res 2006, 84:1350-1357.
13. Stice E., Spoor S., Bohon C., Small D.M. Relation between obesity and blunted striatal response to food is moderated by Taq IA A1 allele. Science 2008, 322:449-452.
14. Kirsch P., Reuter M., Mier D., Lonsdorf T., Stark R., Gallhofer B., et al. Imaging gene-substance interactions: the effect of the DRD2 Taq IA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett 2006, 25(405):196-201.
15. Schott B.H., Minuzzi L., Krebs R.M., Elmenhorst D., Lang M., Winz O.H., et al. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 2008, 28:14311-14319.
16. Blum K., Chen A.L., Chen T.J., Braverman E.R., Reinking J., Blum S.H., et al. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model 2008, 5:24.
17. Althaus M., Groen Y., Wijers A.A., Mulder L.J., Minderaa R.B., Kema I.P., et al. Differential effects of 5-HTTLPR and DRD2/ANKK1 polymorphisms on electrocortical measures of error and feedback processing in children. Clin Neurophysiol 2009, 120:93-107.
18. Ross S., Cidambi I., Dermatis H., Weinstein J., Ziedonis D., Roth S., et al. Music therapy: a novel motivational approach for dually diagnosed patients. J Addict Dis 2008, 27(1):41-53.
19. Goldstein A. Thrills in response to music and other stimuli. Physiol Psychol 1980, 8:126-129.
20. Blum K., Futterman S., Wallace J.E., Schwertner H.A. Naloxone-induced inhibition of ethanol dependence in mice. Nature 1977, 6(265):49-51.
21. Kelly A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002, 22:3306.
22. Knutson B., Adams C.M., Fong G.W., Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 2001, 21:RC159.
23. Robinson T.E., Berridge K.C. Addiction. Ann Rev Psychol 2003, 54:25-53.
24. Mobbs D., Greicius M.D., Abdel-Azim E., Menon V., Reiss A.L. Humor modulates the mesolimbic reward centers. Neuron 2003, 40:1041-1048.
25. Sumners A.D. Humor: coping in recovery from addiction. Issues Ment Health Nurs 1988, 9:169-179.
26. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., Lubar J.O., Chen T.J., Comings D.E. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000, 32(Suppl. i-iv):1-112.
27. Hodgkinson C.A., Yuan Q., Xu K., Shen P.H., Heinz E., Lobos E.A., Binder E.B., Cubells J., Ehlers C.L., Gelernter J., Mann J., Riley B., Roy A., Tabakoff B., Todd R.D., Zhou Z., Goldman D. Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 2008, 43:505-515.
28. Li C.Y., Mao X., Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 2008, 4(1):e2.
29. Wise R.A. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008, 14:169-183.
30. Cocores J.A., Gold M.S. The salted food addiction hypothesis may explain overeating and the obesity epidemic. Med Hypotheses 2009, 28.
31. Blum K., Hamilton M.G., Hirst M., Wallace J.E. Putative role of isoquinoline alkaloids in alcoholism: a link to opiates. Alcohol Clin Exp Res 1978, 2:113-120.
32. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci Biobehav Rev 2006, 30:215-238.
33. Ashby F.G., Isen A.M., Turken A.U. A neuropsychological theory of positive affect and its influence on cognition. Psychol Rev 1999, 106:529-550.
34. Beccera L., Breiter H.C., Wise R., Gonzalaz R.G., Borsook D. Reward circuitry activation by noxious thermal stimuli. Neuron 2001, 32:927-946.
35. Taylor B.K., Joshi C., Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 2003, 987:135-143.
36. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. JR Soc Med 1996, 89:396-400.
37. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 2003, 116B:103-125.
38. Noble E.P., Blum K., Ritchie T., Montgomery A., Sheridan P. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics. Arch Gen Psychiatr 1991, 48:648-654.
39. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001, 21:9414-9418.
40. Hill S.Y., Zezza N., Wipprecht G., Xu J., Neiswanger K. Linkage studies of D2 and D4 receptor genes and alcoholism. Am J Med Genet 1999, 88:676-685.
41. Lobos E.A., Todd R.D. Association analysis in an evolutionary context: cladistic analysis of the DRD2 locus to test for association with alcoholism. Am J Med Genet 1998, 81:411-419.
42. Hietata J., West C., Syvalahti E., Nagren K., Lehikoinen P., et al. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994, 116:285-290.
43. Kuikka J.T., Repo E., Bergstrom K.A., Tupala E., Tiihonen J. Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in the late onset type 1 alcoholic patients. Neurosci Lett 2000, 292:57-59.
44. Volsy J., Swagell C.D., Hughes I.P., Morris C.P., van Deal A., et al. The DRD2 gene 957c
45. Hodge C.W., Chappelle A.M., Samson H.H. Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding. Alcohol Clin Exp Res 1996, 20:1631-1638.
46. Suhara T., Yasuno F., Sudo Y., Yamamoto M., Inoue M., et al. Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking. Neuroimage 2001, 13:891-895.
47. Blum K., Chen A.L.C., Chen T.J.H., Bowirrat A., Downs B.W., et al. Genes and happiness. Gen Ther Mol Biol 2009, 13:92-129.
48. Cohen M.X., Krohn-Grimberghe A., Elger C.E., Weber B. Dopamine gene predicts the brain's response to dopaminergic drug. Eur J Neurosci 2007, 26:3652-3660.
49. Lawford B.R., Young R.M., Rowell J.A., Qualichefski J., Fletcher B.H., et al. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat Med 1995, 1:337-341.
50. Blum K., Chen T.J.H., Chen A.L.H., Rhoades P., Prihoda T.J., Downs B.W., et al. Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands. Gene Ther Mol Biol 2008, 12:129-140.
51. Sorhegui R. New treatment of drug addicts by dishabituation; preliminary report. Arch Med Cuba 1956, 7:45-46.
52. Winick C., Nyswander M. Psychotherapy of successful musicians who are drug addicts. Am J Orthopsychiatr 1961, 31:622-636.
53. Primack B.A., Dalton M.A., Carroll M.V., Agarwal A.A., Fine M.J. Content analysis of tobacco, alcohol, and other drugs in popular music. Arch Pediatr Adolesc Med 2008, 162:169-175.
54. Posluszna J., Burtowy A., Palusinski R. Music preferences and tobacco smoking. Psychol Rep 2004, 94:240-242.
55. Herd D. Changes in the prevalence of alcohol use in rap song lyrics, 1979-1997. Addiction 2005, 100:1258-1269.
56. Beatty W.W., Borrell G.K. Forms of knowledge, cognitive impairment and drug abuse: a demonstration. Prog Neuropsychopharmacol Biol Psychiatr 2000, 24:17-22.
57. Winkelman M. Complementary therapy for addiction: "drumming out drugs" J Public Health 2003, 93:647-651.
58. Goodison L., Schafer H. Drug addiction therapy. A dance to the music of time. Health Serv J 1999, 109:28-29.
59. Levitan D. "This is your Brain on Music" A Plume Book London, England. p. 180.
60. Miller W.R., Johnson W.R. A natural language screening measure for motivation to change. Addict Behav 2008, 33:1177-1182.
61. Bruijnzeel AW, Zislis G, Gold MS. Heightened CRF transmission at least partly mediates anhedonia associated with precipitated nicotine withdrawal in rats. Soc Neurosci 2006; Atlanta, GA.
62. Gold M.S., Miller N.S. Seeking drugs/alcohol and avoiding withdrawal: the neuroanatomy of drive states and withdrawal. Psychiatr Ann 1992, 22:430-435.
63. Dackis C.A., Gold M.S., Sweeney D.R. The physiology of cocaine craving and "crashing" Arch Gen Psychiatr 1987, 44:298-299.
64. Dackis C.A., Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985, 9:469-477.